Tengion is a leading clinical-stage regenerative medicine company. Tengion is currently focused on the development of its pioneering Organ Regeneration Platform to harness the body’s intrinsic regenerative pathways to produce an array of native-like organs and tissues, with the aim of delaying or eliminating the need for chronic disease therapies, organ transplantation and the administration of anti-rejection medications. The company’s most advanced product candidate, the Neo-Urinary Conduit, is currently undergoing an initial clinical trial. For more information, visit the company’s Web site at www.tengion.com.

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research, sales, and trading services. According to Sagient Research Systems, Rodman has been ranked the #1 Placement Agent in terms of the aggregate number of PIPE and RD financing transactions completed every year since 2005. For more information on Rodman & Renshaw, visit www.rodmanandrenshaw.com.

Let us hear your thoughts below: